רבלימיד 15 מ"ג

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Werkstoffen:

LENALIDOMIDE 15 MG

Beschikbaar vanaf:

NEOPHARM SCIENTIFIC LTD

ATC-code:

L04AX04

farmaceutische vorm:

CAPSULES

Toedieningsweg:

PER OS

Geproduceerd door:

CELGENE EUROPE LTD, UK

Therapeutische categorie:

LENALIDOMIDE

therapeutische indicaties:

1. Treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. In combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Autorisatie datum:

2009-04-01